The chart below shows the treatments that were planned during the study and the
number of participants who took each treatment.
Ticagrelor Placebo
• 101 participants • 92 participants
• 15 mg to 45 mg of ticagrelor
• Placebo
based on body weight
• 1 to 3 tablets twice a day • 1 to 3 tablets twice a day
What happened during the study?
Each participant was planned to be in the study for up to 2 years. But, the study
sponsor stopped the study early because the researchers did not think ticagrelor
was helping the participants.
The study started in September 2018 and ended in August 2020.
5 | Clinical Study Results